Ehlers Danlos Syndrome News and Research

RSS
Ehlers-Danlos syndrome (EDS) is a group of inherited disorders that weaken connective tissues. Connective tissues are proteins that support skin, bones, blood vessels and other organs. EDS usually affects your skin, joints and blood vessel walls. Symptoms include loose joints, fragile small blood vessels, abnormal scar formation and wound healing, soft, velvety, stretchy skin that bruises easily. There are several types of EDS. They can range from mild to life-threatening. About 1 in 5,000 people has EDS. There is no cure. Treatment involves managing symptoms. It also includes learning how to protect your joints and prevent injuries.
Study challenges structural explanation for gut symptoms in hEDS patients

Study challenges structural explanation for gut symptoms in hEDS patients

Polygenic analysis provides new insight into hypermobile Ehlers–Danlos syndrome

Polygenic analysis provides new insight into hypermobile Ehlers–Danlos syndrome

New ESC guidelines prioritize women's autonomy in high-risk pregnancies

New ESC guidelines prioritize women's autonomy in high-risk pregnancies

As California’s behavioral health workforce buckles, help is years away

As California’s behavioral health workforce buckles, help is years away

Gender gaps in peripheral vascular disease impact diagnosis and treatment

Gender gaps in peripheral vascular disease impact diagnosis and treatment

Collagen's structural diversity may be greater than previously believed, study suggests

Collagen's structural diversity may be greater than previously believed, study suggests

Many Americans unaware of heart disease risks during pregnancy

Many Americans unaware of heart disease risks during pregnancy

Mount Sinai launches new center for complex chronic illnesses

Mount Sinai launches new center for complex chronic illnesses

TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

TxGNN improves drug repurposing by predicting treatments for rare diseases with no approved therapies

New comprehensive report on pediatric long COVID symptoms published

New comprehensive report on pediatric long COVID symptoms published

Mount Sinai secures $6.2 million grant to expand the Cohen Center for Recovery From Complex Chronic Illnesses

Mount Sinai secures $6.2 million grant to expand the Cohen Center for Recovery From Complex Chronic Illnesses

Decisions by CVS and Optum panicked thousands of their sickest patients

Decisions by CVS and Optum panicked thousands of their sickest patients

Spontaneous coronary artery dissection: The leading cause of pregnancy-associated heart attacks

Spontaneous coronary artery dissection: The leading cause of pregnancy-associated heart attacks

For medically vulnerable families, inflation’s squeeze is inescapable

For medically vulnerable families, inflation’s squeeze is inescapable

Study suggests history of childhood traumas may increase the risk of long COVID

Study suggests history of childhood traumas may increase the risk of long COVID

Researchers report a new genetic cause for infantile fractures

Researchers report a new genetic cause for infantile fractures

Study identifies genetic mutation associated with rare blood vessel disease

Study identifies genetic mutation associated with rare blood vessel disease

Researchers solve the mystery of genetic defect in horses

Researchers solve the mystery of genetic defect in horses

Researchers identify new factor that regulates the size of scar following heart injury

Researchers identify new factor that regulates the size of scar following heart injury

Study reveals key role of a protein in regulating scar tissue growth after heart attacks

Study reveals key role of a protein in regulating scar tissue growth after heart attacks

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.